# FGD6

## Overview
FGD6 is a gene that encodes the protein FYVE, RhoGEF, and PH domain-containing 6, which is a member of the faciogenital dysplasia (FGD) family. This protein functions as a Rho guanine nucleotide exchange factor (GEF) and is involved in intracellular signaling pathways, particularly those regulating the actin cytoskeleton and membrane trafficking. The FGD6 protein is characterized by the presence of several domains, including FYVE, Dbl homology (DH), and pleckstrin homology (PH) domains, which facilitate its interactions with phosphoinositides and small GTPases such as Cdc42. These interactions are crucial for maintaining cell morphology, polarity, and migration. FGD6 plays a significant role in cellular development processes and has been implicated in various clinical conditions, including ocular diseases like polypoidal choroidal vasculopathy (PCV) and neovascular age-related macular degeneration (nAMD) (Chen2020Genetic; Zeng2021Upregulation; Gan2021Association).

## Structure
The FGD6 protein is characterized by the presence of several key domains that contribute to its function in cellular signaling. It contains a FYVE domain, which is involved in binding phosphatidylinositol 3-phosphate, indicating a role in endosomal trafficking (Hasan2022The). The RhoGEF domain is crucial for the regulation of Rho family GTPases, which are important for actin cytoskeleton dynamics (Hasan2022The). The protein also includes a pleckstrin homology (PH) domain, known for its role in binding phosphoinositides, which are important for membrane localization (Hasan2022The).

FGD6 is composed of 1,400 amino acids and is part of the faciogenital dysplasia (FGD) family, which includes proteins with modular architectures such as FYVE domains, Dbl homology (DH), and two PH domains (Zeng2021Upregulation). The protein's domain composition suggests its involvement in cellular development and signaling pathways, including the regulation of the actin cytoskeleton (Zeng2021Upregulation). However, specific details on the primary, secondary, tertiary, or quaternary structures, as well as post-translational modifications or splice variant isoforms, are not provided in the available context.

## Function
The FGD6 gene encodes a protein that functions as a Rho guanine nucleotide exchange factor (GEF), which is involved in intracellular signaling pathways. This protein contains several domains, including FYVE, Dbl homology (DH), and pleckstrin homology (PH) domains, which facilitate interactions with phosphoinositides and small GTPases such as Cdc42. These interactions are crucial for the regulation of the actin cytoskeleton and membrane trafficking processes (Zeng2021Upregulation).

FGD6 plays a significant role in coordinating cell polarity and endosomal membrane recycling, particularly in osteoclasts. It achieves this by regulating the assembly of various actin-based protein networks and activating Cdc42 at different cellular locations. This activity is essential for maintaining proper cell morphology and migration, which are critical for normal cellular development and function (Zeng2021Upregulation).

In healthy human cells, FGD6 is involved in the regulation of cellular development processes, although specific details about its functions in these cells are not extensively documented. Its role in actin cytoskeleton regulation suggests it may influence cell shape and movement, contributing to broader developmental processes (Zeng2021Upregulation).

## Clinical Significance
The FGD6 gene has been implicated in several ocular conditions, particularly polypoidal choroidal vasculopathy (PCV) and neovascular age-related macular degeneration (nAMD). In a study involving a Chinese population, the single nucleotide polymorphism (SNP) rs77466370 in FGD6 was significantly associated with PCV, with an odds ratio (OR) of 2.12, but not with choroidal neovascularization (CNV), which had an OR of 1.13 (Gan2021Association). The T allele of this SNP showed a strong association with PCV, with a summary OR of 1.86, suggesting its role in the pathogenesis of PCV. The variant FGD6-Arg329, compared to FGD6-Lys329, exhibits a different intracellular localization pattern and promotes abnormal vessel development in the mouse retina, indicating its involvement in PCV (Gan2021Association).

Exome sequencing in Chinese cohorts identified a rare p.Lys329Arg variant in FGD6 as significantly associated with PCV, but not with nAMD, suggesting differential effects of FGD6 variants on these conditions (Chen2020Genetic). Another rare variant, p.Gln257Arg, was identified for nAMD, indicating potential differential roles of FGD6 in these diseases (Chen2020Genetic). These findings highlight the importance of genetic studies in understanding the disease mechanisms associated with FGD6.

## Interactions
FGD6 is involved in several interactions that play a crucial role in cellular processes. It is a downstream target of the transcription factor EHF, which regulates its expression in the context of neutrophil recruitment in hepatocellular carcinoma (HCC) (Luan2021Identifying). FGD6 is known to interact with CDC42, a small GTPase, which is involved in cell adhesion, cell polarity, and membrane recycling. This interaction suggests that FGD6 may influence these cellular processes by regulating actin-based protein networks (Luan2021Identifying).

FGD6 is also highly correlated in expression with RIC8B and SIPA1L3, indicating potential collaborative roles in the regulation of GTPase activity and cytoskeleton organization. These proteins are implicated in the Rap1 signaling pathway, which is important for endothelial barrier regulation, vasculogenesis, and angiogenesis (Luan2021Identifying). The interaction of FGD6 with these proteins suggests its involvement in cell adhesion, migration, and polarity through the activation of CDC42 (Luan2021Identifying).

While specific physical interactions of FGD6 with other proteins or nucleic acids are not detailed, its role in these pathways highlights its importance in cellular signaling and structural organization (Luan2021Identifying).


## References


[1. (Chen2020Genetic) Li Jia Chen. Genetic association of age-related macular degeneration and polypoidal choroidal vasculopathy. Asia-Pacific Journal of Ophthalmology, 9(2):104–109, March 2020. URL: http://dx.doi.org/10.1097/01.APO.0000656976.47696.7d, doi:10.1097/01.apo.0000656976.47696.7d. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1097/01.APO.0000656976.47696.7d)

[2. (Zeng2021Upregulation) Jianmin Zeng, Man Li, Huasheng Shi, and Jianhui Guo. Upregulation of fgd6 predicts poor prognosis in gastric cancer. Frontiers in Medicine, July 2021. URL: http://dx.doi.org/10.3389/fmed.2021.672595, doi:10.3389/fmed.2021.672595. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmed.2021.672595)

[3. (Gan2021Association) Li Gan, Bo Gong, and Zhenglin Yang. Association Studies on Retina Diseases in Chinese Population, pages 133–138. Springer Singapore, 2021. URL: http://dx.doi.org/10.1007/978-981-15-9184-6_10, doi:10.1007/978-981-15-9184-6_10. This article has 0 citations.](https://doi.org/10.1007/978-981-15-9184-6_10)

[4. (Luan2021Identifying) Mingyuan Luan, Xue Tian, Dexiang Zhang, Xiaoning Sun, Minglu Jiang, Yunbo Duan, Changgang Sun, and Hongzong Si. Identifying the potential regulators of neutrophils recruitment in hepatocellular carcinoma using bioinformatics method. Translational Cancer Research, 10(2):724–737, February 2021. URL: http://dx.doi.org/10.21037/tcr-20-2714, doi:10.21037/tcr-20-2714. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.21037/tcr-20-2714)

[5. (Hasan2022The) Mahmudul Hasan and Daniel Capelluto. The ph domain and c-terminal polyd motif of phafin2 exhibit a unique concurrence in animals. Membranes, 12(7):696, July 2022. URL: http://dx.doi.org/10.3390/membranes12070696, doi:10.3390/membranes12070696. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/membranes12070696)